ESC 365 - One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – CON.

Open Access

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – CON.

Session: The 2020 NSTE - ACS guidelines in practice – the pros and cons

Topic: Acute Coronary Syndromes

Speaker: Professor G. Montalescot (Paris, FR)

Event: ACVC 2021

Congress Presentation

About the speaker

Professor Gilles Montalescot

Pitie Salpetriere APHP University Hospital, Paris (France)

24 presentations

1 follower

5 more presentations in this session

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - PRO.

Speaker: Professor C. Mueller (Basel, CH)

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - CON.

Speaker: Assistant Professor E. Giannitsis (Heidelberg, DE)

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - Discussion.

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – PRO.

Speaker: Professor R. Lopes (Durham, US)

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – Discussion.

Access the full session

The 2020 NSTE - ACS guidelines in practice – the pros and cons

Speakers: Professor G. Montalescot, Professor C. Mueller, Assistant Professor E. Giannitsis, Professor R. Lopes

About the event

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Congress

Related content

Open Access

Optimizing your CRT in 2022.

3 April 2022

Open Access

Conduction system pacing: from his to the septum.

3 April 2022

ACVC Premium Access

Optimal management of acute right ventricular failure: know it to treat it - discussion.

18 March 2022

ESC 365 is supported by